Key statistics
On Thursday, Conduit Pharmaceuticals Inc (CDT:NMQ) closed at 0.1079, 36.76% above the 52 week low of 0.0789 set on Nov 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1447 |
---|---|
High | 0.1579 |
Low | 0.1021 |
Bid | 0.1036 |
Offer | 0.109 |
Previous close | 0.0923 |
Average volume | 64.46m |
---|---|
Shares outstanding | 102.85m |
Free float | 53.35m |
P/E (TTM) | -- |
Market cap | 11.10m USD |
EPS (TTM) | -0.1708 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
- Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
- Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
- Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
- Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
- Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
- Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
- Conduit Pharmaceuticals to Join Russell 3000® Index
- Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
More ▼